Q3 2019 Earnings Forecast for Henry Schein, Inc. (HSIC) Issued By Barrington Research

Henry Schein, Inc. (NASDAQ:HSIC) – Barrington Research increased their Q3 2019 earnings estimates for shares of Henry Schein in a report released on Wednesday, May 8th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $0.90 per share for the quarter, up from their previous estimate of $0.84. Barrington Research has a “Outperform” rating and a $75.00 price objective on the stock. Barrington Research also issued estimates for Henry Schein’s Q4 2019 earnings at $0.97 EPS, FY2019 earnings at $3.46 EPS and FY2020 earnings at $3.78 EPS.

Other analysts have also issued research reports about the stock. Craig Hallum cut their price objective on shares of Henry Schein from $96.00 to $72.00 and set a “buy” rating on the stock in a research report on Tuesday, February 19th. Guggenheim started coverage on shares of Henry Schein in a research report on Wednesday, April 17th. They issued a “buy” rating and a $72.00 price objective on the stock. Zacks Investment Research raised shares of Henry Schein from a “hold” rating to a “buy” rating and set a $78.00 price objective on the stock in a research report on Monday. Barclays cut their price objective on shares of Henry Schein from $73.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 21st. Finally, ValuEngine raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Monday, February 4th. Six research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $76.71.



Shares of HSIC stock opened at $66.97 on Monday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.68 and a current ratio of 1.65. The firm has a market capitalization of $10.32 billion, a PE ratio of 16.22, a price-to-earnings-growth ratio of 2.56 and a beta of 0.89. Henry Schein has a 12 month low of $56.58 and a 12 month high of $91.35.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.80 EPS for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.04. The business had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.36 billion. Henry Schein had a net margin of 4.10% and a return on equity of 18.35%. The firm’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.95 earnings per share.

Several institutional investors and hedge funds have recently modified their holdings of HSIC. Tyers Asset Management LLC grew its stake in shares of Henry Schein by 6.7% in the first quarter. Tyers Asset Management LLC now owns 59,584 shares of the company’s stock valued at $3,582,000 after acquiring an additional 3,744 shares in the last quarter. Lazard Asset Management LLC grew its stake in shares of Henry Schein by 8.1% in the first quarter. Lazard Asset Management LLC now owns 210,049 shares of the company’s stock valued at $12,625,000 after acquiring an additional 15,694 shares in the last quarter. Zuckerman Investment Group LLC grew its stake in shares of Henry Schein by 42.7% in the first quarter. Zuckerman Investment Group LLC now owns 317,467 shares of the company’s stock valued at $19,083,000 after acquiring an additional 95,002 shares in the last quarter. Duality Advisers LP grew its stake in shares of Henry Schein by 81.2% in the first quarter. Duality Advisers LP now owns 82,700 shares of the company’s stock valued at $4,971,000 after acquiring an additional 37,050 shares in the last quarter. Finally, Wilbanks Smith & Thomas Asset Management LLC grew its stake in shares of Henry Schein by 37.1% in the first quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 4,618 shares of the company’s stock valued at $278,000 after acquiring an additional 1,250 shares in the last quarter.

In other news, Director Philip A. Laskawy sold 1,084 shares of the stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total value of $64,888.24. Following the transaction, the director now directly owns 32,899 shares of the company’s stock, valued at $1,969,334.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Philip A. Laskawy sold 3,591 shares of the stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $59.12, for a total transaction of $212,299.92. The disclosure for this sale can be found here. Corporate insiders own 1.06% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More: What is a resistance level?

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.